Lubiprostone
- Product NDC
- 10370-266
- 11-digit product format
- 103700266
- Labeler code
- 10370
- Product ID
- 10370-266_bbbc1583-077b-44ac-a860-32221b21a291
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lubiprostone
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Par Pharmaceutical, Inc.
- Application
- ANDA201442
- Marketing category
- ANDA
- Marketing start
- 2020-01-01
- Marketing end
- 0000-00-00
- Substance
- LUBIPROSTONE
- Active strength
- 8 ug/1
- Pharmacologic classes
- Chloride Channel Activator [EPC], Chloride Channel Activators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 10370-266-02 | 10370026602 | 60 CAPSULE in 1 BOTTLE (10370-266-02) | 60 capsule | 2020-01-01 | 0000-00-00 | No | No | Current |